SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-23-016560
Filing Date
2023-05-08
Accepted
2023-05-08 18:29:07
Documents
1
Period of Report
2023-05-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_168358492995664.html 4  
1 FORM 4 wf-form4_168358492995664.xml 4 5836
  Complete submission text file 0001628280-23-016560.txt   7517
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Issuer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEORX CORP 410 WEST HARRISON ST SEATTLE WA 98119
Business Address
GIVEN DOUGLAS B (Reporting) CIK: 0001156207 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38042 | Film No.: 23899366